{"id":4106,"date":"2026-06-09T09:04:09","date_gmt":"2026-06-09T16:04:09","guid":{"rendered":"https:\/\/xpharma.com.cn\/?p=4106"},"modified":"2026-06-09T09:04:10","modified_gmt":"2026-06-09T16:04:10","slug":"zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china","status":"publish","type":"post","link":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/","title":{"rendered":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>On June 9, Zai Lab announced that its ADC novel drug Tisotumab Vedotin has received its first marketing approval in China for the treatment of adult patients with recurrent or metastatic cervical cancer who have progressed during or after chemotherapy.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tisotumab Vedotin is a tissue factor (TF)-targeting ADC<\/strong>&nbsp;composed of Genmab&#8217;s human monoclonal antibody targeting TF and Pfizer&#8217;s ADC technology, which utilizes a protease-cleavable linker to covalently conjugate the microtubule-disrupting agent monomethyl auristatin E (MMAE) to the antibody.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buy <strong>TIVDAK\u00ae<\/strong><strong>\uff08<\/strong><strong>Tisotumab<\/strong><strong>\uff09<\/strong><strong>&nbsp;<\/strong>online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On June 9, Zai Lab announced that its ADC novel drug Tisotumab Vedotin has received its first marketing approval in China for the treatment of adult patients with recurrent or metastatic cervical cancer who have progressed during or after chemotherapy. Tisotumab Vedotin is a tissue factor (TF)-targeting ADC&nbsp;composed of Genmab&#8217;s human monoclonal antibody targeting TF [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2708,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-4106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China<\/title>\n<meta name=\"description\" content=\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-\uff1ativdaktisotumab-vedotinapproved-for-marketing-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China\" \/>\n<meta property=\"og:description\" content=\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-\uff1ativdaktisotumab-vedotinapproved-for-marketing-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"Xpharma China\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/61590027634719\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T16:04:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T16:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/zailab.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"344\" \/>\n\t<meta property=\"og:image:height\" content=\"146\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"xpharmanews\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:site\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"xpharmanews\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/\"},\"author\":{\"name\":\"xpharmanews\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\"},\"headline\":\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China.\",\"datePublished\":\"2026-06-09T16:04:09+00:00\",\"dateModified\":\"2026-06-09T16:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/\"},\"wordCount\":124,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zailab.jpg\",\"articleSection\":[\"Approved News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/\",\"name\":\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zailab.jpg\",\"datePublished\":\"2026-06-09T16:04:09+00:00\",\"dateModified\":\"2026-06-09T16:04:10+00:00\",\"description\":\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zailab.jpg\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zailab.jpg\",\"width\":344,\"height\":146,\"caption\":\"zailab\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/xpharma.com.cn\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"name\":\"Xpharma China - International Pharmaceutical wholesaler and retailer\",\"description\":\"Xpharma China\",\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xpharma.com.cn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\",\"name\":\"Xpharma China\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"width\":679,\"height\":166,\"caption\":\"Xpharma China\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/61590027634719\\\/\",\"https:\\\/\\\/x.com\\\/Xpharma007\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\",\"name\":\"xpharmanews\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"caption\":\"xpharmanews\"},\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/author\\\/xpharmanews\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China","description":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-\uff1ativdaktisotumab-vedotinapproved-for-marketing-in-china\/","og_locale":"en_US","og_type":"article","og_title":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China","og_description":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China","og_url":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-\uff1ativdaktisotumab-vedotinapproved-for-marketing-in-china\/","og_site_name":"Xpharma China","article_publisher":"https:\/\/www.facebook.com\/61590027634719\/","article_published_time":"2026-06-09T16:04:09+00:00","article_modified_time":"2026-06-09T16:04:10+00:00","og_image":[{"width":344,"height":146,"url":"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/zailab.jpg","type":"image\/jpeg"}],"author":"xpharmanews","twitter_card":"summary_large_image","twitter_creator":"@Xpharma007","twitter_site":"@Xpharma007","twitter_misc":{"Written by":"xpharmanews","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#article","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/"},"author":{"name":"xpharmanews","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05"},"headline":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China.","datePublished":"2026-06-09T16:04:09+00:00","dateModified":"2026-06-09T16:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/"},"wordCount":124,"commentCount":0,"publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/zailab.jpg","articleSection":["Approved News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/","url":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/","name":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#primaryimage"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/zailab.jpg","datePublished":"2026-06-09T16:04:09+00:00","dateModified":"2026-06-09T16:04:10+00:00","description":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China. - Xpharma China","breadcrumb":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#primaryimage","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/zailab.jpg","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/zailab.jpg","width":344,"height":146,"caption":"zailab"},{"@type":"BreadcrumbList","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/zai-lab-%ef%bc%9ativdaktisotumab-vedotinapproved-for-marketing-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/xpharma.com.cn\/"},{"@type":"ListItem","position":2,"name":"Zai Lab\u00a0\uff1aTIVDAK\u00aeTisotumab vedotinapproved for marketing in China."}]},{"@type":"WebSite","@id":"https:\/\/xpharma.com.cn\/#website","url":"https:\/\/xpharma.com.cn\/","name":"Xpharma China - International Pharmaceutical wholesaler and retailer","description":"Xpharma China","publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xpharma.com.cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xpharma.com.cn\/#organization","name":"Xpharma China","url":"https:\/\/xpharma.com.cn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","width":679,"height":166,"caption":"Xpharma China"},"image":{"@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/61590027634719\/","https:\/\/x.com\/Xpharma007"]},{"@type":"Person","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05","name":"xpharmanews","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","caption":"xpharmanews"},"url":"https:\/\/xpharma.com.cn\/index.php\/author\/xpharmanews\/"}]}},"_links":{"self":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/4106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/comments?post=4106"}],"version-history":[{"count":1,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/4106\/revisions"}],"predecessor-version":[{"id":4107,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/4106\/revisions\/4107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media\/2708"}],"wp:attachment":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media?parent=4106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/categories?post=4106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/tags?post=4106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}